# Japan Ophthalmic Viscoelastic Devices Market

> Japan Ophthalmic Viscoelastic Devices Market Research Report: Size, Share, Trend Analysis By Types (Cohesive OVDs, Dispersive OVDs), By Applications (Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, Vitreoretinal Surgery) and By End Users (Ophthalmic Clinics & Phaco Centers, Hospitals, Academic & Research Institutes) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 4.99%
- **2024:** $ 95.85 Million
- **2025:** $ 145.8 Million
- **2035:** $ 163.8 Million
- **Key Players:** Alcon (CH), Bausch + Lomb (US), Johnson & Johnson (US), Carl Zeiss (DE), Santen Pharmaceutical (JP), Hoya Corporation (JP), MediWound (IL), Oculentis (DE), Kowa Company (JP)

**Report ID:** MRFR/MED/54231-HCR · **Pages:** 200 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** February 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/japan-ophthalmic-viscoelastic-devices-market-55997

---

## Market Summary

## **Japan Ophthalmic Viscoelastic Devices Market Overview**

As per MRFR analysis, the Japan Ophthalmic Viscoelastic Devices Market Size was estimated at 178.75 (USD Million) in 2023. The Japan Ophthalmic Viscoelastic Devices Market Industry is expected to grow from 191.88(USD Million) in 2024 to 734 (USD Million) by 2035. The Japan Ophthalmic Viscoelastic Devices Market CAGR (growth rate) is expected to be around 12.972% during the forecast period (2025 - 2035).

**Key Japan Ophthalmic Viscoelastic Devices Market Trends Highlighted**

The Japan Ophthalmic Viscoelastic Devices Market is shaped by several vital market drivers that influence its growth trajectory. The aging population in Japan significantly impacts the demand for ophthalmic procedures as age-related eye conditions like cataracts and glaucoma become more prevalent.

This demographic trend creates a sustained need for viscoelastic devices during surgeries such as cataract extractions and intraocular lens implantations. Furthermore, advancements in technology lead to the development of innovative viscoelastic products that enhance surgical outcomes and increase safety, thereby driving market growth.

Opportunities to be explored within this market include the potential for collaboration between Japanese manufacturers and international companies to leverage expertise and broaden product offerings.Further shifts in eco-friendly practices focus on creating biodegradable viscoelastic devices, paying attention to rising environmental awareness in Japan. Moreover, additional funding in research and development could provide unique solutions for unmet clinical challenges and improve the efficiency of surgical procedures.

Recently, there has been a significant trend toward minimally invasive surgical procedures in the field of ophthalmology in Japan. Both doctors as well as patients are increasingly opting for viscoelastic devices that enable faster recovery and fewer complications, thereby decreasing the overall recovery time. There is also a higher increasing trend with respect to awareness about eye care, encouraging more people to undergo routine examinations and treatments that, in turn, increase the need for ophthalmic devices.

As technology evolves, the integration of digital solutions, such as telemedicine for follow-ups, is also gaining traction in the Japanese healthcare landscape, further shaping the market dynamics for ophthalmic viscoelastic devices.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Japan Ophthalmic Viscoelastic Devices Market Drivers**

**Increasing Aging Population in Japan**

Japan has one of the most rapidly aging populations in the world, which significantly drives the Japan Ophthalmic Viscoelastic Devices Market Industry. According to the Ministry of Internal Affairs and Communications in Japan, by 2025, it is expected that 29.1% of the population will be 65 years or older.

This increase contributes to a higher prevalence of age-related eye diseases such as cataracts and glaucoma, which require surgical interventions utilizing ophthalmic viscoelastic devices.

Furthermore, the Japan National Institute of Population and Social Security Research reports that the number of people aged 75 years and over has already reached approximately 17 million, with projections indicating that this figure may rise to 25 million by 2040. Such demographic shifts necessitate advanced surgical procedures, thereby directly leading to greater demand for ophthalmic viscoelastic devices in Japan.

**Technological Advancements in Surgical Procedures**

The Japan Ophthalmic Viscoelastic Devices Market Industry is witnessing accelerated growth due to significant advancements in surgical techniques and devices. Innovations such as femtosecond laser-assisted cataract surgery and minimally invasive surgical techniques are raising the safety and effectiveness of procedures.

According to a report from the Japan Society of Ophthalmology, the adoption of these technologies has led to improved surgical outcomes, with studies indicating a 20% reduction in complication rates in cataract surgeries.Major players like Alcon and Bausch + Lomb are investing heavily in Research and Development to improve their viscoelastic device offerings, leading to wider acceptance in surgical practices and facilitating market growth.

**Rising Prevalence of Eye Disorders**

The prevalence of eye disorders in Japan is on the rise, particularly due to lifestyle changes and a lack of regular eye check-ups. The World Health Organization estimates that around 5.89 million people in Japan suffer from severe visual impairment, a statistic that emphasizes the urgent need for surgical solutions.

Additionally, the Ministry of Health, Labour and Welfare has reported an increasing diagnosis rate for eye disorders, with incidences of diabetic retinopathy and age-related macular degeneration growing by approximately 10% over the last decade.The increasing number of surgeries to correct these conditions directly boosts the demand for ophthalmic viscoelastic devices, positioning this market for even more robust growth in the coming years.

**Government Initiatives and Healthcare Reforms**

Government policies aimed at improving healthcare accessibility in Japan are also propelling the Japan Ophthalmic Viscoelastic Devices Market Industry forward. The Japanese government has implemented various healthcare reforms to enhance the quality and accessibility of medical services, particularly for elderly patients.

The establishment of the Healthcare and Medical Strategy Headquarters has led to increased funding for advanced medical technologies and surgical treatments.According to the Ministry of Health, Labour and Welfare, the government plans to invest an additional 1.8 trillion Yen in medical technology by 2025, which is expected to enhance the procurement of innovative surgical materials, including ophthalmic viscoelastic devices. These initiatives underscore the supportive policy environment that fosters growth in this market.

**Japan Ophthalmic Viscoelastic Devices Market Segment Insights**

**Ophthalmic Viscoelastic Devices Market Type Insights**

The Japan Ophthalmic Viscoelastic Devices Market is segmented into various types, notably including Cohesive OVDs and Dispersive OVDs. The market is expected to showcase robust growth, driven by an increasing number of ophthalmic surgical procedures prompted by a rising prevalence of eye disorders within the population. The Cohesive OVDs segment is particularly significant, as these devices effectively maintain anterior chamber stability and aid in the protection of the corneal endothelium during surgery.

This characteristic is vital in procedures such as cataract surgery, where maintaining clear access and visibility is paramount for optimal outcomes.In contrast, Dispersive OVDs serve a different yet essential role, often preferred for their ability to coat intraocular surfaces and minimize postoperative inflammation.

As the aging population in Japan continues to expand, the demand for various surgical interventions will likely increase, propelling the need for advanced ophthalmic viscoelastic devices. Additionally, innovations in product design and formulations are anticipated to enhance patient outcomes and surgical efficiency, further contributing to the significance of these segments within the broader Japan Ophthalmic Viscoelastic Devices Market.

The interplay between technological advancements and the growing healthcare infrastructure in Japan is expected to create a conducive environment for the expansion of both Cohesive and Dispersive OVDs, thereby influencing overall market growth.

The increasing emphasis on minimally invasive surgical techniques in ophthalmology also underscores the relevance of these types, as they are integral to improving surgical precision and patient recovery times. Overall, both types of ophthalmic viscoelastic devices play a pivotal role in enhancing surgical practices and improving patient comfort, signifying their indispensable presence in Japan's evolving ophthalmic sector.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Ophthalmic Viscoelastic Devices Market Application Insights**

The Application segment of the Japan Ophthalmic Viscoelastic Devices Market encompasses critical procedures such as Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, and Vitreoretinal Surgery. With the aging population in Japan, the demand for Cataract Surgery is notably significant, as cataracts remain a primary cause of visual impairment.

Likewise, Glaucoma Surgery is on the rise due to an increase in glaucoma incidences, further underscoring the necessity of effective devices to maintain eye pressure. Corneal Transplantation is vital in restoring vision in patients with corneal diseases, making advanced viscoelastic devices essential for success during surgery.

Vitreoretinal Surgery addresses various retinal disorders, where the safety and efficacy of viscoelastic devices can play a pivotal role. Collectively, these applications contribute to enhanced surgical outcomes and patient satisfaction in Japan, driven by technological advancements and increasing healthcare accessibility.

The continuous evolution of surgical techniques and the rising prevalence of eye conditions in the aging demographic positions this segment as a significant growth area within the Japan Ophthalmic Viscoelastic Devices Market.Furthermore, ongoing Research and Development efforts in this field promise to yield innovative solutions, thus meeting the diverse needs of ophthalmic procedures.

**Ophthalmic Viscoelastic Devices Market End User Insights**

The End User segment of the Japan Ophthalmic Viscoelastic Devices Market presents a diverse landscape shaped by the needs of various facilities, primarily including Ophthalmic Clinics and Phaco Centers, Hospitals, as well as Academic and Research Institutes.

Ophthalmic Clinics and Phaco Centers hold a crucial role in the delivery of specialized eye care services, particularly in cataract surgeries where viscoelastic devices are integral to maintaining anterior chamber stability. Hospitals account for a substantial portion of the overall services, providing a wide range of surgical interventions and eye care solutions, which necessitates the utilization of advanced viscoelastic products to enhance surgical outcomes and patient safety.

Academic and Research Institutes contribute significantly to innovation within the market, focusing on the development and testing of new technologies that can improve ocular procedures, thus fostering advancements in Research and Development that drive market growth.

The synergy between these segments is pivotal in addressing the increasing demand for effective ophthalmic procedures, promoting advancements in medical technology, and improving patient care standards across Japan. The growing emphasis on patient safety and surgical efficacy across these segments further enhances the significance of viscoelastic devices, positioning them as essential tools in contemporary ophthalmic practices.

**Japan Ophthalmic Viscoelastic Devices Market Key Players and Competitive Insights**

The Japan Ophthalmic Viscoelastic Devices Market is characterized by growing competition among various key players that are persistently striving to enhance their product offerings and expand their market share.

The market landscape is influenced by advancements in technology, the increasing prevalence of eye disorders, and a rising number of cataract surgeries, which contribute to the demand for ophthalmic viscoelastic devices. The competitive dynamics in this market are shaped by both local and international manufacturers, who are focusing on research and development to innovate and improve the efficacy and safety profiles of their products.

As the market evolves, companies are increasingly forming strategic partnerships and collaborations to leverage their strengths and enhance their competitive position while addressing the needs of healthcare professionals and patients alike.

Oculentis stands out in the Japan Ophthalmic Viscoelastic Devices Market with its strong brand reputation and commitment to quality. The company focuses on providing high-performance viscoelastic solutions that cater to a variety of surgical needs during cataract procedures. Oculentis possesses a distinguished ability to blend innovation with efficiency, which has garnered trust among ophthalmic surgeons and healthcare providers in Japan.

The company ensures that its products not only meet but exceed regulatory requirements, contributing significantly to its robust market presence. With a dedicated approach to customer education and a consistent effort to gather feedback for product improvements, Oculentis has solidified its position as a prominent player in this competitive landscape, characterized by a heightened focus on surgical outcomes and patient satisfaction.Surfacematch has established a notable presence in the Japan Ophthalmic Viscoelastic Devices Market, primarily recognized for its innovative approach to viscoelastic products designed for ophthalmic surgeries.

The company provides a range of specialized devices that enhance surgical precision and patient outcomes. Surfacematch's strengths lie in its commitment to research and development, leading to the introduction of new and improved formulations that cater specifically to the needs of ophthalmic surgeons in Japan. The company emphasizes strategic collaborations and partnerships, which not only enhance its product portfolio but also widen its reach in the market.

This strategy has proven effective in positioning Surfacematch as a competitive player amidst the evolving demands of the ophthalmic device segment. Additionally, the company is actively pursuing mergers and acquisitions to bolster its capacity for innovation and expand its market footprint in Japan, aligning with the increasing trends in minimally invasive surgical techniques and personalized patient care.

**Key Companies in the Japan Ophthalmic Viscoelastic Devices Market Include**

- Oculentis
- Surfacematch
- Abbott Laboratories
- Bausch Health
- Santen Pharmaceutical
- Hoya Corporation
- Rhein Medical
- Carl Zeiss AG
- Moria Surgical
- Kowa Company
- Merck KGaA
- Alcon
- Johnson & Johnson
- ShinEtsu Chemical

**Japan Ophthalmic Viscoelastic Devices Market Industry Developments**

Recent developments in the Japan Ophthalmic Viscoelastic Devices Market highlight a dynamic landscape driven by innovation and strategic activities among key players. In August 2023, Santen Pharmaceutical announced the expansion of its product line, focusing on advanced viscoelastic formulations emphasizing technological advancements tailored to local market needs. Meanwhile, in September 2023, Alcon reported a notable increase in market share attributed to its latest surgical products targeting cataract and glaucoma procedures.

The growth of companies such as Hoya Corporation and Merck KGaA is indicative of the rising demand for ophthalmic solutions across Japan, bolstered by an aging population and increasing visual impairment issues. Notably, in July 2023, Bausch Health acquired a smaller company specializing in innovative ophthalmic technologies, which has further strengthened its position in the market.

Rhein Medical also shared plans for product enhancement and partnerships aimed at improving surgical outcomes. These activities collectively reflect the robust investment and competitive strategies of companies like Abbott Laboratories, Moria Surgical, and Johnson and Johnson, aiming to elevate market value and meet growing consumer demands in Japan's ophthalmic sector.

**Japan Ophthalmic Viscoelastic Devices Market Segmentation Insights**

**Ophthalmic Viscoelastic Devices Market Type****Outlook**

- Cohesive OVDs
- Dispersive OVDs

**Ophthalmic Viscoelastic Devices Market Application****Outlook**

- Cataract Surgery
- Glaucoma Surgery
- Corneal Transplantation
- Vitreoretinal Surgery

**Ophthalmic Viscoelastic Devices Market End User****Outlook**

- Ophthalmic Clinics & Phaco Centers
- Hospitals
- Academic & Research Institutes

## Market Drivers

### Rising Prevalence of Eye Disorders

The increasing incidence of eye disorders in Japan is a pivotal driver for the Japan Ophthalmic Viscoelastic Devices Market. Conditions such as cataracts and glaucoma are becoming more prevalent, particularly among the aging population. According to recent health statistics, approximately 3 million people in Japan are affected by cataracts, necessitating surgical interventions that utilize viscoelastic devices. This growing patient demographic is likely to propel demand for advanced ophthalmic surgical tools, including viscoelastic agents, which are essential for maintaining intraocular pressure and protecting ocular tissues during procedures. As the population ages, the market for these devices is expected to expand, indicating a robust growth trajectory for the japan ophthalmic viscoelastic devices market.

### Growing Demand for Aesthetic Eye Procedures

The rising popularity of aesthetic eye procedures is emerging as a significant driver for the Japan Ophthalmic Viscoelastic Devices Market. As consumers become more conscious of their appearance, there is an increasing demand for procedures such as eyelid surgery and cosmetic enhancements that utilize viscoelastic materials. This trend is particularly pronounced in urban areas, where aesthetic procedures are more widely accepted. The market for viscoelastic devices is likely to benefit from this growing interest, as these materials are essential for ensuring optimal results in cosmetic surgeries. Consequently, the japan ophthalmic viscoelastic devices market may experience substantial growth as aesthetic procedures gain traction among the population.

### Government Initiatives and Healthcare Policies

Government initiatives aimed at improving healthcare infrastructure and access to eye care services are crucial for the Japan Ophthalmic Viscoelastic Devices Market. The Japanese government has implemented various policies to enhance the quality of healthcare, including increased funding for ophthalmic research and development. These initiatives are likely to stimulate innovation in the production of viscoelastic devices, ensuring that they meet the evolving needs of healthcare providers. Furthermore, the establishment of national health programs focused on eye health is expected to increase awareness and demand for surgical interventions, thereby positively impacting the market for ophthalmic viscoelastic devices in Japan.

### Increased Investment in Research and Development

Investment in research and development (R&D) within the ophthalmic sector is a critical driver for the Japan Ophthalmic Viscoelastic Devices Market. Japanese companies are increasingly allocating resources to innovate and improve viscoelastic products, focusing on enhancing their properties and applications. This commitment to R&D is likely to yield new formulations that offer superior performance in surgical settings. Additionally, collaborations between academic institutions and industry players are fostering advancements in ophthalmic technologies. As a result, the market is expected to witness a surge in innovative viscoelastic devices that cater to the specific needs of surgeons and patients, thereby propelling growth in the japan ophthalmic viscoelastic devices market.

### Technological Innovations in Surgical Techniques

Technological advancements in surgical techniques are significantly influencing the Japan Ophthalmic Viscoelastic Devices Market. Innovations such as minimally invasive surgeries and the development of new viscoelastic formulations enhance surgical outcomes and patient safety. For instance, the introduction of cohesive and dispersive viscoelastic agents has improved the efficiency of cataract surgeries, leading to quicker recovery times. The market is witnessing a shift towards more sophisticated devices that offer better performance and ease of use for surgeons. This trend is expected to drive the adoption of viscoelastic devices, as healthcare providers seek to incorporate the latest technologies into their practices, thereby fostering growth in the japan ophthalmic viscoelastic devices market.

## Future Outlook

The Japan [ophthalmic viscoelastic devices market](https://www.marketresearchfuture.com/reports/ophthalmic-viscoelastic-devices-market-1396) is projected to grow at a 4.99% CAGR from 2025 to 2035, driven by technological advancements and increasing surgical procedures.

**New opportunities:**

- Development of biodegradable viscoelastic devices for enhanced patient safety.
- Expansion into telemedicine platforms for remote consultations and follow-ups.
- Strategic partnerships with surgical centers to streamline device distribution.

By 2035, the market is expected to solidify its position as a leader in ophthalmic innovations.

## Segment Insights

### By Application: Cataract Surgery (Largest) vs. Glaucoma Surgery (Fastest-Growing)

In the Japan Ophthalmic Viscoelastic Devices Market, the application segment is predominantly shaped by cataract surgery, holding the largest market share. This segment is significantly supported by the rising prevalence of cataracts among the aging population, leading to an increased demand for surgical interventions. Glaucoma surgery, while smaller in market share, shows promising growth as awareness and early detection efforts rise, driving the adoption of viscoelastic devices in these procedures.

The growth trends within the application segment are primarily driven by advancements in surgical techniques and the integration of innovative viscoelastic materials. As technologies improve, both cataract and glaucoma surgeries are becoming more successful, thus encouraging broader use of these devices. With an aging population and increasing cases of eye disorders, the demand for effective treatment options will continue to grow, propelling both established and emerging segments forward in the coming years.

Cataract Surgery (Dominant) vs. Glaucoma Surgery (Emerging)

Cataract surgery stands as the dominant application in the Japan ophthalmic viscoelastic devices market, characterized by its widespread acceptance and integration into routine ophthalmic care. This segment benefits from established surgical protocols and a strong support system for patients, leading to high procedure volume. On the other hand, glaucoma surgery is emerging as a notable segment, driven by growing concerns about glaucoma prevalence and the development of advanced surgical techniques. The increasing number of patients requiring glaucoma management opens opportunities for innovative viscoelastic solutions. As ophthalmologists adopt new technologies to enhance surgical outcomes, both cataract and glaucoma surgery segments are poised for growth, albeit at different rates, influencing the overall dynamics of the market.

### By Product Type: Sodium Hyaluronate (Largest) vs. Chondroitin Sulfate (Fastest-Growing)

In the Japan Ophthalmic Viscoelastic Devices Market, Sodium Hyaluronate holds the largest market share due to its widespread use in cataract surgeries and other ophthalmic procedures. This biopolymer is favored for its excellent viscoelastic properties, which facilitate better surgical outcomes. Chondroitin Sulfate, while smaller in market share, is gaining traction as an emerging product type thanks to its unique benefits in stabilizing the eye and reducing post-operative complications.

Sodium Hyaluronate (Dominant) vs. Chondroitin Sulfate (Emerging)

Sodium Hyaluronate is recognized as the dominant product type within the Japan ophthalmic viscoelastic devices market, owing to its high efficiency in maintaining eye pressure during surgery and its role in promoting healing. It is widely utilized in cataract surgeries and is known for its safety profile. Chondroitin Sulfate, on the other hand, is emerging as a competitive alternative, particularly valued for its anti-inflammatory properties and its role in reducing corneal damage. As innovations continue, Chondroitin Sulfate’s growing recognition among surgeons positions it as an important player in the evolving landscape.

### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the Japan Ophthalmic Viscoelastic Devices Market, hospitals hold the largest share among end users, reflecting their capacity for extensive surgical procedures and availability of advanced technologies. Ambulatory Surgical Centers (ASCs) are emerging as a significant player, driven by a shift towards outpatient surgeries, which cater to an increasing patient base seeking efficient and minimally invasive procedures.

The growth trends within these segments indicate a rising demand for surgical interventions, particularly among elderly populations suffering from various eye conditions. Technological advancements in viscoelastic devices are enhancing procedural efficacy, contributing to an uptick in adoption across hospitals and ASCs. This shift also mirrors healthcare policies in Japan, promoting outpatient care and leading to substantial investments in ASCs.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals are the dominant end users of ophthalmic viscoelastic devices in Japan, leveraging their ability to invest in high-quality medical equipment and provide comprehensive care for complicated eye surgeries. Their established infrastructure and skilled professionals ensure patient safety and surgical success, making them a preferred option for complex ophthalmic procedures. Conversely, Ambulatory Surgical Centers are emerging as a key contender, gaining traction due to their focus on outpatient care and procedural efficiency. These centers cater to patients seeking quick recovery and minimal hospital stays, thus driving demand for innovative viscoelastic solutions. As patient preferences shift towards less invasive procedures, ASCs are adapting rapidly, heralding a significant change in the landscape of ophthalmic surgery.

### By Distribution Channel: Direct Sales (Largest) vs. Online Sales (Fastest-Growing)

In the Japan Ophthalmic Viscoelastic Devices Market, the distribution channels are broadly categorized into direct sales, distributors, and online sales. Direct sales hold the largest market share, primarily due to strong relationships between manufacturers and healthcare providers, enabling personalized service and immediate access to products. Online sales, however, while currently smaller in terms of share, are gaining traction as more healthcare professionals turn to digital platforms for convenience and efficiency in procurement. Distributors play a solid role in bridging the gap between manufacturers and end users, ensuring that products are widely available across different regions in Japan.

Sales Channels: Direct Sales (Dominant) vs. Online Sales (Emerging)

Direct sales in the Japan ophthalmic viscoelastic devices market are characterized by manufacturers dealing directly with healthcare facilities, allowing for tailored solutions and enhanced customer support. This model thrives on strong personal relationships and reliability. Online sales, on the other hand, are rapidly emerging as a viable alternative, catering to the tech-savvy segment of the market. The convenience of ordering supplies online, coupled with the rise in e-commerce adoption in the medical field, positions online sales as a critical channel for future growth. The increasing competition is forcing both channels to innovate and enhance their value propositions, balancing traditional service with modern accessibility.

## Competitive Benchmarking

The ophthalmic viscoelastic devices market in Japan is characterized by a competitive landscape that is both dynamic and multifaceted. Key growth drivers include an aging population, increasing prevalence of eye disorders, and advancements in surgical techniques. Major players such as Alcon (CH), Bausch + Lomb (US), and Santen Pharmaceutical (JP) are strategically positioned to leverage these trends. Alcon (CH) focuses on innovation in product development, particularly in enhancing the performance of viscoelastic devices, while Bausch + Lomb (US) emphasizes strategic partnerships to expand its market reach. Santen Pharmaceutical (JP) is actively pursuing regional expansion, particularly in Asia, to capitalize on emerging market opportunities. Collectively, these strategies contribute to a competitive environment that is increasingly centered around innovation and market responsiveness.

In terms of business tactics, companies are localizing manufacturing to reduce costs and improve supply chain efficiency. The market structure appears moderately fragmented, with several key players holding significant market shares. This fragmentation allows for a diverse range of products and innovations, although it also intensifies competition among established and emerging firms.

In December 2025, Alcon (CH) announced the launch of a new line of viscoelastic devices designed specifically for cataract surgery, which is expected to enhance surgical outcomes and patient satisfaction. This strategic move underscores Alcon's commitment to innovation and its focus on addressing the specific needs of surgeons and patients in the Japanese market. The introduction of these advanced products may strengthen Alcon's competitive position and drive market growth.

In November 2025, Santen Pharmaceutical (JP) entered into a collaboration with a leading technology firm to integrate AI into its product development processes. This partnership aims to streamline research and development, potentially accelerating the time-to-market for new viscoelastic devices. By leveraging AI, Santen could enhance its product offerings and maintain a competitive edge in a rapidly evolving market.

In October 2025, Bausch + Lomb (US) expanded its distribution network in Japan through a strategic alliance with local healthcare providers. This move is likely to enhance the accessibility of its viscoelastic devices, thereby increasing market penetration. The collaboration with local entities may also facilitate better understanding of regional market dynamics, allowing Bausch + Lomb to tailor its offerings more effectively.

As of January 2026, current trends in the ophthalmic viscoelastic devices market include a pronounced shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is expected to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift may redefine market dynamics, compelling companies to invest in R&D and collaborative initiatives to stay ahead in a competitive environment.

## Recent News & Developments

Recent developments in the Japan Ophthalmic Viscoelastic Devices Market highlight a dynamic landscape driven by innovation and strategic activities among key players. In August 2023, Santen Pharmaceutical announced the expansion of its product line, focusing on advanced viscoelastic formulations emphasizing technological advancements tailored to local market needs. Meanwhile, in September 2023, Alcon reported a notable increase in market share attributed to its latest surgical products targeting cataract and glaucoma procedures.

The growth of companies such as Hoya Corporation and Merck KGaA is indicative of the rising demand for ophthalmic solutions across Japan, bolstered by an aging population and increasing visual impairment issues. Notably, in July 2023, Bausch Health acquired a smaller company specializing in innovative ophthalmic technologies, which has further strengthened its position in the market.

Rhein Medical also shared plans for product enhancement and partnerships aimed at improving surgical outcomes. These activities collectively reflect the robust investment and competitive strategies of companies like Abbott Laboratories, Moria Surgical, and Johnson and Johnson, aiming to elevate market value and meet growing consumer demands in Japan's ophthalmic sector.

## Report Scope

| MARKET SIZE 2024 | 95.85(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 145.8(USD Million) |
| MARKET SIZE 2035 | 163.8(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.99% (2024 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Alcon (CH), Bausch + Lomb (US), Johnson & Johnson (US), Carl Zeiss (DE), Santen Pharmaceutical (JP), Hoya Corporation (JP), MediWound (IL), Oculentis (DE), Kowa Company (JP) |
| Segments Covered | Application, Product Type, End User, Distribution Channel |
| Key Market Opportunities | Advancements in minimally invasive surgical techniques drive demand for innovative ophthalmic viscoelastic devices in Japan. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation in Japan's ophthalmic viscoelastic devices market. |
| Countries Covered | Japan |

## Frequently Asked Questions

**Q: What is the current valuation of the Japan ophthalmic viscoelastic devices market as of 2026?**
A: The market valuation is projected to reach approximately 95.85 USD Million in 2024.

**Q: What is the expected compound annual growth rate (CAGR) for the Japan ophthalmic viscoelastic devices market from 2025 to 2035?**
A: The expected CAGR during the forecast period 2025 - 2035 is 4.99%.

**Q: Which application segments are driving the Japan ophthalmic viscoelastic devices market?**
A: Cataract surgery, glaucoma surgery, corneal surgery, and retinal surgery are key application segments, with cataract surgery valued at 65.0 USD Million in 2024.

**Q: What are the leading product types in the Japan ophthalmic viscoelastic devices market?**
A: Sodium hyaluronate and combination products are leading product types, with sodium hyaluronate valued at 50.0 USD Million in 2024.

**Q: Who are the key players in the Japan ophthalmic viscoelastic devices market?**
A: Key players include Alcon, Bausch + Lomb, Johnson & Johnson, and Santen Pharmaceutical.

**Q: What distribution channels are utilized in the Japan ophthalmic viscoelastic devices market?**
A: The market utilizes direct sales, distributors, and online sales, with direct sales valued at 66.12 USD Million in 2024.

**Q: What is the projected market valuation for the Japan ophthalmic viscoelastic devices market in 2035?**
A: The market is projected to reach approximately 163.8 USD Million by 2035.

**Q: Which end-user segments are prominent in the Japan ophthalmic viscoelastic devices market?**
A: Hospitals, ambulatory surgical centers, and ophthalmic clinics are prominent end-user segments, with hospitals valued at 65.0 USD Million in 2024.

**Q: How does the market for chondroitin sulfate compare to other product types in 2024?**
A: Chondroitin sulfate is valued at 30.0 USD Million in 2024, indicating strong demand compared to other product types.

**Q: What trends are anticipated in the Japan ophthalmic viscoelastic devices market by 2035?**
A: The market is likely to experience growth driven by advancements in surgical techniques and increasing demand for ophthalmic procedures.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/japan-ophthalmic-viscoelastic-devices-market-55997*